Search research articles
Contact Us
Filters
Showing results (171-180 of 187) with videos related to
Page
of 19
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
February 25, 1980
Genetic approaches to attenuation of influenza A viruses for man
B R Murphy, L J Markoff, R M Chanock, et al.
Fungal Genetics and Biology : FG & B
|
June 5, 2007
A systematic analysis of T-DNA insertion events in Magnaporthe oryzae
Yan Meng, Gayatri Patel, Melanie Heist, et al.
Pain
|
February 7, 2009
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster
Robert H Dworkin, Richard L Barbano, Stephen K Tyring, et al.
The Journal of Infectious Diseases
|
August 3, 2013
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults
Kathleen M Mullane, Drew J Winston, Michael S Wertheim, et al.
Infection and Immunity
|
June 1, 1978
Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers
B R Murphy, L J Markoff, N T Hosier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 8, 2009
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis
Robert F Betts, Marcio Nucci, Deepak Talwar, et al.
Fungal Genetics and Biology : FG & B
|
June 30, 2007
Development of a high throughput transformation system for insertional mutagenesis in Magnaporthe oryzae
Melania F Betts, Sara L Tucker, Natalia Galadima, et al.
The Journal of Infectious Diseases
|
August 3, 2013
Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine
Myron J Levin, Kenneth E Schmader, John W Gnann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 2012
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years
Kenneth E Schmader, Myron J Levin, John W Gnann, et al.
Infection and Immunity
|
August 1, 1980
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers
B R Murphy, M B Rennels, R G Douglas, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 187) with videos related to
Sort By:
Page
of 19
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
February 25, 1980
Genetic approaches to attenuation of influenza A viruses for man
B R Murphy, L J Markoff, R M Chanock, et al.
Fungal Genetics and Biology : FG & B
|
June 5, 2007
A systematic analysis of T-DNA insertion events in Magnaporthe oryzae
Yan Meng, Gayatri Patel, Melanie Heist, et al.
Pain
|
February 7, 2009
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster
Robert H Dworkin, Richard L Barbano, Stephen K Tyring, et al.
The Journal of Infectious Diseases
|
August 3, 2013
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults
Kathleen M Mullane, Drew J Winston, Michael S Wertheim, et al.
Infection and Immunity
|
June 1, 1978
Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers
B R Murphy, L J Markoff, N T Hosier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 8, 2009
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis
Robert F Betts, Marcio Nucci, Deepak Talwar, et al.
Fungal Genetics and Biology : FG & B
|
June 30, 2007
Development of a high throughput transformation system for insertional mutagenesis in Magnaporthe oryzae
Melania F Betts, Sara L Tucker, Natalia Galadima, et al.
The Journal of Infectious Diseases
|
August 3, 2013
Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine
Myron J Levin, Kenneth E Schmader, John W Gnann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 2012
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years
Kenneth E Schmader, Myron J Levin, John W Gnann, et al.
Infection and Immunity
|
August 1, 1980
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers
B R Murphy, M B Rennels, R G Douglas, et al.
Page
of 19